Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer (Q60469517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S Mariotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

R D'Alessandro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M Roselli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

A Spila

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S Aloe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M D Carone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

M R Abbolito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

S Carlini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

P Perri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

A Ricciotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

C Botti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

F Conti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

P Vici

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

N R Chiappetta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

F Cognetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

F Guadagni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

9-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11678313%20AND%20SRC:MED&resulttype=core&format=json

Value of CA 15:3 in the follow-up of breast cancer patients

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

CA 549 as a Marker in Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Monoclonal Antibody M3 Used in Tissue Polypeptide&ndash;Specific Antigen Assay for the Quantification of Tissue Polypeptide Antigen Recognizes Keratin 18

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Cytokeratin markers in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Serum markers for monitoring of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

TPS in breast cancer--a comparative study with carcinoembryonic antigen and CA 15-3

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Tissue polypeptide specific antigen (TPS) in breast cancer--an initial evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

CA549 and TPS patterns in the diagnosis and staging of patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Expression of cytokeratins in regenerating human epidermis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

Influence of Neoadjuvant Chemotherapy on Serum Tumor Markers CA 15-3, MCA, CEA, TPS and TPA in Breast Cancer Patients with Operable Disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021

The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1017903724176

7 January 2021